¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"surface membrane proteins"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • fetal membrane
    žƸ·
  • fibroelastic membrane
    ¼¶À¯Åº·Â¸·
  • fibrous membrane
    ¼¶À¯¸·
  • glassy membrane
    À¯¸®Áú¸·
  • glial limiting membrane
    ¾Æ±³°æ°è¸·, ±³¼¼Æ÷°æ°è¸·
  • hemoendothelial membrane
    Ç÷¾×³»ÇǸ·
  • hyaline membrane
    À¯¸®Áú¸·
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • hyaloid membrane
    À¯¸®Ã¼¸·
  • ion-exchange membrane
    À̿±³È¯¸·
  • iridopupillary membrane
    ȫ䵿°ø¸·
  • intercostal membrane
    °¥ºñ»çÀ̸·, ´Á°£¸·
  • interosseous membrane
    »À»çÀ̸·, °ñ°£¸·
  • limiting membrane
    °æ°è¸·
  • mucous membrane
    Á¡¸·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • membrane current
    ¸·Àü·ù
  • decidual membrane
    Å»¶ô¸·
  • definitive fetal membrane
    ¿Ï¼ºÅ¾Ƹ·
  • dentinoenamel membrane
    Çü¼ºÀü¸·, »ó¾Æ»ç±âÁú¸·
  • Descemet¡¯s membrane
    µÚ°æ°èÆÇ, µ¥½º¸Þ¸·
  • different membrane protein
    À¯°ü¸·´Ü¹é
  • diphtheritic membrane
    µðÇÁÅ׸®¾Æ¸·
  • drum membrane
    (¢¡tympanic membrane) °í¸·
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • membrane dissection
    ¸·ºÐ¸®
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×
  • egg membrane
    ³­¸·
  • elastic membrane
    ź·Â¸·
  • enamel membrane
    »ç±âÁú¸·
  • excitable membrane
    ÈïºÐ¸·
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
  • anterior hyaloid membrane
    ¾ÕÀ¯¸®Ã¼¸·
  • anterior limiting membrane
    ¾Õ°æ°èÆÇ
  • anterior vitreous membrane
    ¾Õ(Àü)À¯¸®Ã¼¸·
  • artificial membrane
    Àΰø¸·(Àΰø¸·).
  • glassy membrane
    À¯¸®¸·.
  • glomerular basement membrane
    »ç__¼±âÀú¸__¡­Ðñî¼Ø¯).
  • glomerular basement membrane
    »ç±¸Ã¼±âÀú¸·(¡­Ðñî¼Ø¯).
  • glomerular membrane
    »ç±¸Ã¼¸·(¡­Ø¯).
  • glomerular membrane
    »ç±¸Ã¼¸·.
  • hemochorial membrane
    Ç÷¾×À¶¸ð¸·
  • hemodichorial membrane
    Ç÷¾×µÎ°ãÀ¶¸ð¸·
  • hemoendothelial membrane
    Ç÷¾×³»ÇÇ»çÀ̸·
  • hemomonochorial membrane
    Ç÷¾×Ȭ°ãÀ¶¸ð¸·
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • gluteal surface
    µÐºÎ±Ù¸é, µÐ±Ù¸é(ÔëÐÉØü).
  • gluteal surface
    º¼±â±Ù¸é
  • hepatitis B surface antigen (HBs Ag)
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • hepatitis B surface antigen(HBs Ag)
    BÇü °£¿°Ç¥¸éÇ׿ø
  • immunoglobulin, surface
    ¼¼Æ÷Ç¥¸é ¸é¿ª±Û·ÎºÒ¸°
  • impression of root surface
    ±Ù¸éÀλó(ÐÆØü ìÔßÚ).
  • incisal surface
    Àý´Ü¸é(ôîÓ®Øü).
  • inferior articular surface
    ¾Æ·¡°üÀý¸é
  • inferior surface
    ¾Æ·¡¸é
  • inferior surface of petrous portion
    ¹ÙÀ§¾Æ·¡¸é
  • inferior surface of tongue
    Çô¾Æ·¡¸é
  • inferolateral surface
    ¾Æ·¡°¡Âʸé
  • infratemporal surface
    °üÀھƷ¡¸é
  • interlobar surface
    ¿±»çÀ̸é
  • internal pelvic surface ³ª facies sacropelvina
    õ°ñ¹Ý¸é.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Urethral surface
    ¿äµµ¸é
    [¿¾ ¿ë¾î] ¿äµµ¸é
  • Superolateral surface
    À§°¡Âʸé
    [¿¾ ¿ë¾î] »ó¿ÜÃø¸é
  • Superior articular surface
    À§°üÀýµ¹±â
    [¿¾ ¿ë¾î] »ó°üÀýµ¹±â
  • Superior articular surface
    À§°üÀý¸é
    [¿¾ ¿ë¾î] »ó°üÀý¸é
  • Gastric surface
    À§¸é
    [¿¾ ¿ë¾î] À§¸é
  • Superior surface
    À§¸é
    [¿¾ ¿ë¾î] »ó¸é
  • Maxillary surface
    À§Åθé
    [¿¾ ¿ë¾î] »ó¾Ç¸é
  • Dorsal surface
    À½°æµî
    [¿¾ ¿ë¾î] À½°æ¹è
  • Articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
    [¿¾ ¿ë¾î] ÀÔ¹æ°ñ°üÀý¸é
  • Labial surface
    ÀÔ¼ú¸é
    [¿¾ ¿ë¾î] ±¸¼ø¸é
  • Palatine surface
    ÀÔõÀå¸é
    [¿¾ ¿ë¾î] ±¸°³¸é
  • Approximal surface
    Á¢Ã˸é
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Articular surface for fibula
    Á¾¾Æ¸®°üÀý¸é
    [¿¾ ¿ë¾î] ºñ°ñ°üÀý¸é
  • Articular surface of fibular head
    Á¾¾Æ¸®»À¸Ó¸®°üÀý¸é
    [¿¾ ¿ë¾î] ºñ°ñµÎ°üÀý¸é
  • Colic surface
    ÁÖ¸§Ã¢ÀÚ¸é
    [¿¾ ¿ë¾î] °áÀå¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
anti-HBs antibody to hepatitis B surface antigen
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
BSA benzenesulfonic acid; Biofeedback Society of America; bismuth-sulfite agar; bis-trimethylsilyl-aceta...
BSB body surface burned
Cs case; cell surface; cesium; cyclosporine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
RGS proteins Regulators of G protein signaling
SIRP Signal-regulatory proteins
SSBs Single-stranded DNA binding proteins
SASP Small, acid-soluble spore proteins
sHSP Small heat shock proteins
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • free surface
    ÀÚÀ¯ ¸é
  • high surface
    °íÇ¥¸é
  • impression of root surface
    ±Ù¸é Àλó
  • impression surface
    Àλó¸é
    ±¸°­ Á¶Á÷ÀÇ ÀÎ»ó¿¡ ÀÇÇØ¼­ °áÁ¤µÈ ÀÇÄ¡ÀÇ Ç¥¸é.
  • inferior surface
    ¾Æ·¡ ¸é
  • inferior surface of tongue
    Çô ¾Æ·¡ ¸é
  • interfacial surface tension
    ÀÇÄ¡ Ç¥¸é Àå·Â
    ÀÇÄ¡ÀÇ Á¢ÇÕµµ°¡ ÁÁÀº °æ¿ì¿¡ À־ ÀÇÄ¡»ó°ú Á¶Á÷°úÀÇ »çÀÌ¿¡ ¾×ü°¡ ¾ãÀº ¸·À¸·Î Çü¼ºµÇ¾î ÀÇÄ¡ÀÇ Å»¶ôÀ» ¹æÁöÇÑ ÀúÇ×·ÂÀÌ´Ù.
  • jugular surface
    °æÁ¤¸Æ Ç¥¸é
  • keratotic surface
    °¢Áú Ç¥¸é
  • labial surface
    ¼ø¸é, ÀüÁ¤¸é
    1. ÀÔ¼ú ÂÊÀ¸·Î ÇâÇÑ ¸é. 2. Ä¡¾ÆÀÇ ÀÔ¼úÃø ¸é.
  • large surface form
    ³ÐÀº ¸éÀÇ ÇüÅÂ
  • laser cavity surface
    ·¹ÀÌÀú Çü¼º ¿Íµ¿¸é
    ·¹ÀÌÀú¸¦ »ç¿ëÇØ Ä¡¾Æ ¿ì½ÄºÎ¸¦ Á¦°ÅÇÏ°í ¿Íµ¿À» Çü¼ºÇÑ ¸é.
  • malleolar articular surface
    ³»°ú °üÀý¸é, ³»Ãø º¹»ç °üÀý¸é
  • masticatory surface
    ±³ÇÕ ¸é
    À§, ¾Æ·¡ À̰¡ ¸Â¹°¸®´Â ¸é.
  • maxillary surface
    »ó¾Ç ¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
proto-oncogene proteins c-bcl-2 Membrane proteins encoded by the bcl-2 genes and serving as a potent inhibitor of cell death by apoptosis. The proteins are found on mitochondrial, microsomal, and nuclear membrane sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma.
(12 Dec 1998)
proto-oncogene proteins c-erbb-2 Cellular proteins in the epidermal growth factor receptor family encoded by the c-erbb genes. These proteins are overexpressed in a significant portion of adenocarcinomas found at various sites, especially in the breast. Gene amplification appears to be the predominant method leading to overexpression.
(12 Dec 1998)
proto-oncogene proteins c-fos Cellular DNA-binding proteins encoded by the c-fos genes (genes, fos). They are involved in growth-related transcriptional control. C-fos combines with c-jun (proto-oncogene proteins c-jun) to form a c-fos/c-jun heterodimer (transcription factor ap-1) that binds to the tre (tpa-responsive element) in promoters of certain genes.
(12 Dec 1998)
proto-oncogene proteins c-jun Cellular DNA-binding proteins encoded by the c-jun genes (genes, jun). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun.
(12 Dec 1998)
proto-oncogene proteins c-kit Tyrosine kinase membrane receptors which are the natural ligands for mast cell growth factor (steel factor). This interaction is crucial for the development of haematopoietic, gonadal, and pigment stem cells.
(12 Dec 1998)
proto-oncogene proteins c-met <enzyme> A transmembrane tyrosine kinase that is the receptor for hepatocyte growth factor (scatter factor). It consists of an extracellular alpha chain which is disulfide linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and critical sites for the regulation of kinase activity.
Registry number: EC 2.7.11.-
(12 Dec 1998)
proto-oncogene proteins c-mos Cellular proteins encoded by the c-mos genes (genes, mos). They function in the cell cycle to maintain maturation-promoting factor in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.
(12 Dec 1998)
proto-oncogene proteins c-myc Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumourigenesis.
(12 Dec 1998)
proto-oncogene proteins c-raf <enzyme> A class of serine-threonine kinases involved in cellular signal transduction. Included in this class are the proto-oncogene proteins mil and raf. Raf is a component of a signal transduction pathway leading to increased gene expression through the c-jun DNA binding site, ap1.
Registry number: EC 2.7.10.-
(12 Dec 1998)
protozoan proteins Proteins found in any species of protozoan.
(12 Dec 1998)
prpc proteins Normal cellular isoform of prion proteins (prions) encoded by a chromosomal gene and found in normal and scrapie-infected brain tissue, and other normal tissue. Prpc are protease-sensitive proteins whose function is unknown. Posttranslational modification of prpc into prpsc leads to infectivity.
(12 Dec 1998)
prpsc proteins Abnormal isoform of prion proteins (prions) resulting from a posttranslational modification of the cellular prion protein (prpc proteins). Prpsc are disease-specific proteins seen in certain human and animal neurodegenerative diseases (prion diseases).
(12 Dec 1998)
high mobility group proteins Family of small, nonhistone, nuclear proteins. Some appear to be involved in controlling transcription.
(18 Nov 1997)
homeodomain proteins Proteins encoded by homeobox genes (genes, homeobox) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (gene expression regulation, developmental).
(12 Dec 1998)
homologous proteins <molecular biology> Proteins that look similar and work in similar ways in different species.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á